DE69730317D1 - N-acetylcystein und boxonubicin enthaltende pharmazeutische zusammensetzung zur hemmung der krebsmetastasierung - Google Patents

N-acetylcystein und boxonubicin enthaltende pharmazeutische zusammensetzung zur hemmung der krebsmetastasierung

Info

Publication number
DE69730317D1
DE69730317D1 DE69730317T DE69730317T DE69730317D1 DE 69730317 D1 DE69730317 D1 DE 69730317D1 DE 69730317 T DE69730317 T DE 69730317T DE 69730317 T DE69730317 T DE 69730317T DE 69730317 D1 DE69730317 D1 DE 69730317D1
Authority
DE
Germany
Prior art keywords
metasas
boxonubicin
acetylcystein
pharmaceutical composition
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69730317T
Other languages
English (en)
Inventor
Flora Silvio De
Adriana Albini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon SpA
Original Assignee
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon SpA filed Critical Zambon SpA
Application granted granted Critical
Publication of DE69730317D1 publication Critical patent/DE69730317D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
DE69730317T 1996-02-14 1997-02-12 N-acetylcystein und boxonubicin enthaltende pharmazeutische zusammensetzung zur hemmung der krebsmetastasierung Expired - Lifetime DE69730317D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI000277A IT1282625B1 (it) 1996-02-14 1996-02-14 Composizione farmaceutica atta ad inibire la formazione di metastasi tumorali
PCT/EP1997/000627 WO1997029759A1 (en) 1996-02-14 1997-02-12 Pharmaceutical composition enabling to inhibit cancer metastasis formation containing n-acetyl-cysteine and doxorubicin

Publications (1)

Publication Number Publication Date
DE69730317D1 true DE69730317D1 (de) 2004-09-23

Family

ID=11373264

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69730317T Expired - Lifetime DE69730317D1 (de) 1996-02-14 1997-02-12 N-acetylcystein und boxonubicin enthaltende pharmazeutische zusammensetzung zur hemmung der krebsmetastasierung

Country Status (7)

Country Link
EP (1) EP0885006B1 (de)
JP (1) JP2000504704A (de)
AT (1) ATE273710T1 (de)
CA (1) CA2245863A1 (de)
DE (1) DE69730317D1 (de)
IT (1) IT1282625B1 (de)
WO (1) WO1997029759A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19926154A1 (de) * 1999-06-09 2000-12-14 Ktb Tumorforschungs Gmbh Verfahren zur Herstellung einer injizierbaren Arzneimittelzubereitung
WO2006008270A1 (de) * 2004-07-22 2006-01-26 Thiomatrix Forschungs- Und Beratungs Gmbh Verwendung von thiolgruppen-hältigen verbindungen als efflux-pumpen-hemmer
JP5634862B2 (ja) 2007-05-16 2014-12-03 カーテーベー トゥモーアフォルシュングス ゲゼルシャフト ミット ベシュレンクテル ハフツング 低粘度アントラサイクリン製剤
WO2011110838A2 (en) * 2010-03-08 2011-09-15 Procure Therapeutics Limited Differentiation factor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4331648A (en) * 1979-12-05 1982-05-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services N-Acetyl-cysteine protects against cardiac damage from subsequently-administered cardio-toxic anthra-cycline in cancer therapy
US4873088A (en) * 1983-09-06 1989-10-10 Liposome Technology, Inc. Liposome drug delivery method and composition

Also Published As

Publication number Publication date
JP2000504704A (ja) 2000-04-18
CA2245863A1 (en) 1997-08-21
EP0885006B1 (de) 2004-08-18
ATE273710T1 (de) 2004-09-15
WO1997029759A1 (en) 1997-08-21
EP0885006A1 (de) 1998-12-23
ITMI960277A1 (it) 1997-08-14
ITMI960277A0 (de) 1996-02-14
IT1282625B1 (it) 1998-03-31

Similar Documents

Publication Publication Date Title
IL123889A0 (en) Pharmaceutical angiostatic dipeptide compositions and methods of use thereof
GEP20022784B (en) Celecoxib Composition
NZ503233A (en) Synergistic analgesic combination of opioid analgesic and COX-2 inhibitor
HUT70405A (en) A pharmaceutical composition containing a defined lipid system
MX9700552A (es) Conjugados de vitamina b12 y proteinas.
MY132705A (en) Novel compounds with analgesic effect
IL76932A (en) Synergistic pharmaceutical analgesic compositions containing dihydrocodeine and ibuprofen
GB9401894D0 (en) New compositions of matter
ATE427103T1 (de) Orale verabreichung von adenosin analogen
AU2874099A (en) Low molecular weight compounds administered together with anti-cancer agents to treat cancer and pharmaceutical compositions thereof
WO2001078783A3 (en) Compositions comprising natural agents for treatment of cancer
HUP0302635A2 (hu) Valpronsav foszfolipidszármazékai és ezek keveréke
HUP0100539A2 (hu) D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására
IL150953A0 (en) A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
DE69730317D1 (de) N-acetylcystein und boxonubicin enthaltende pharmazeutische zusammensetzung zur hemmung der krebsmetastasierung
DK0927031T3 (da) Farmaceutisk sammensætning indeholdende nimesulid til oral admnistration
IL147901A0 (en) Phenanthroline-7-one derivatives and their therapeutic uses
DE69918124T2 (de) Zusammensetzungen und Vorrichtungen zur transdermalen Verabreichung von Fenoldopam
DK1202992T3 (da) Ascididemin-derivater og terapeutiske anvendelser deraf
HUP9701051A2 (hu) Természetes hatóanyagú, gyógyhatású készítmények
UA30359A (uk) Спосіб лікування гнійних ран

Legal Events

Date Code Title Description
8332 No legal effect for de